How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?

OBJECTIVES To compare the use of pair-wise meta-analysis methods to multiple treatment comparison (MTC) methods for evidence-based health-care evaluation to estimate the effectiveness and cost-effectiveness of alternative health-care interventions based on the available evidence. METHODS Pair-wise meta-analysis and more complex evidence syntheses, incorporating an MTC component, are applied to three examples: 1) clinical effectiveness of interventions for preventing strokes in people with atrial fibrillation; 2) clinical and cost-effectiveness of using drug-eluting stents in percutaneous coronary intervention in patients with coronary artery disease; and 3) clinical and cost-effectiveness of using neuraminidase inhibitors in the treatment of influenza. We compare the two synthesis approaches with respect to the assumptions made, empirical estimates produced, and conclusions drawn. RESULTS The difference between point estimates of effectiveness produced by the pair-wise and MTC approaches was generally unpredictable-sometimes agreeing closely whereas in other instances differing considerably. In all three examples, the MTC approach allowed the inclusion of randomized controlled trial evidence ignored in the pair-wise meta-analysis approach. This generally increased the precision of the effectiveness estimates from the MTC model. CONCLUSIONS The MTC approach to synthesis allows the evidence base on clinical effectiveness to be treated as a coherent whole, include more data, and sometimes relax the assumptions made in the pair-wise approaches. However, MTC models are necessarily more complex than those developed for pair-wise meta-analysis and thus could be seen as less transparent. Therefore, it is important that model details and the assumptions made are carefully reported alongside the results.

[1]  Neil Hawkins,et al.  How Far Do You Go? Efficient Searching for Indirect Evidence , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[2]  Carl van Walraven,et al.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. , 2002, JAMA.

[3]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[4]  A Haycox,et al.  Drug-eluting stents: a systematic review and economic evaluation. , 2007, Health technology assessment.

[5]  Alex J. Sutton,et al.  Methods for Meta-Analysis in Medical Research , 2000 .

[6]  David J. Spiegelhalter,et al.  WinBUGS user manual version 1.4 , 2003 .

[7]  M. Pfisterer,et al.  Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis , 2008, BMJ : British Medical Journal.

[8]  S. Goodman,et al.  Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. , 2000, Journal of general internal medicine.

[9]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[10]  T. Lumley Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.

[11]  D. Singer Overview of the randomized trials to prevent stroke in atrial fibrillation. , 1993, Annals of epidemiology.

[12]  M. Cowles Modelling Survival Data in Medical Research (2nd ed.) (Book) , 2004 .

[13]  Gordon H Guyatt,et al.  Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison , 2009, Trials.

[14]  D. Collett Modelling survival data , 1994 .

[15]  S. Ebrahim,et al.  Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation , 2001, BMJ : British Medical Journal.

[16]  A. Sutton,et al.  Systematic review and economic decision modelling for the prevention and treatment of influenza A and B: neuraminidase inhibitors for prevention , 2003 .

[17]  A E Ades,et al.  Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B , 2008, Statistics in medicine.

[18]  A. Kazanjian,et al.  Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. , 1997, The Canadian journal of cardiology.

[19]  David Collett Modelling Survival Data in Medical Research , 1994 .

[20]  David Turner,et al.  Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. , 2004, Health economics.

[21]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[22]  Keith Abrams,et al.  Use of Indirect and Mixed Treatment Comparisons for Technology Assessment , 2012, PharmacoEconomics.

[23]  K Abrams,et al.  Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. , 2003, Health technology assessment.

[24]  A E Ades,et al.  Meta‐analysis of mixed treatment comparisons at multiple follow‐up times , 2007, Statistics in medicine.

[25]  R. Hart,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 2000 .

[26]  A E Ades,et al.  Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. , 2009, Health technology assessment.

[27]  Nicola J Cooper,et al.  Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. , 2006, Archives of internal medicine.

[28]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.